We are at a critical junction with this. It does
Post# of 154797
(Total Views: 674)
Posted On: 07/09/2020 2:33:10 PM
We are at a critical junction with this. It does seem that in a short time, the questions will be answered and we will know just how effective Leron will be for many indications but the board needs to really get the message together and have facts to back up what is being said. I can say the sky is blue but until there's proof it is, it could very well be red or green. People need to see and consume the data. Until that happens, we may have ups and downs that really try the patience of everyone here.
I've listened to many of these calls and my perspective is I've heard this so many times over the last several years that I have it memorized. We really need hard, factual evidence that Leron will work and do what we know it will do. The convincing is not the shareholders but the naysayers. I do think the people in the company are moving toward that and REALLY appreciate the fact that the approach is make sure the data is valid and all the I's are dotted before making public statements. I'd much rather had silence than the really amateur presentation that the Wall Street Reporter hosted. I'd ask for my money back from them.
Where is the PR group that the company pays in these presentations? They should be coordinating and reviewing presentations and prepping Nadar. I would think that they would at least proof read the presentations and not allow spelling errors on the initial slide. Not a big thing but Cytodyn is getting prepared to move into the big leagues. Time to act like it.
I'm long on this company, love the fact that it is going to change the paradigm in healthcare. I'm keeping all my stock long term and will hold on and ride the waves but let's get our act together and do it soon please.
All in my humble opinion. Go Cytodyn!
I've listened to many of these calls and my perspective is I've heard this so many times over the last several years that I have it memorized. We really need hard, factual evidence that Leron will work and do what we know it will do. The convincing is not the shareholders but the naysayers. I do think the people in the company are moving toward that and REALLY appreciate the fact that the approach is make sure the data is valid and all the I's are dotted before making public statements. I'd much rather had silence than the really amateur presentation that the Wall Street Reporter hosted. I'd ask for my money back from them.
Where is the PR group that the company pays in these presentations? They should be coordinating and reviewing presentations and prepping Nadar. I would think that they would at least proof read the presentations and not allow spelling errors on the initial slide. Not a big thing but Cytodyn is getting prepared to move into the big leagues. Time to act like it.
I'm long on this company, love the fact that it is going to change the paradigm in healthcare. I'm keeping all my stock long term and will hold on and ride the waves but let's get our act together and do it soon please.
All in my humble opinion. Go Cytodyn!
(4)
(0)